These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6653667)
1. Hemodynamic effects of the arteriolar vasodilators hydralazine, dihydralazine and endralazine in the conscious spontaneously hypertensive rat. Struyker-Boudier HA; van Essen H; Smits JF Eur J Pharmacol; 1983 Nov; 95(3-4):151-9. PubMed ID: 6653667 [TBL] [Abstract][Full Text] [Related]
2. [Comparative hemodynamic effects of 2 vasodilators: dihydralazine and diltiazem in permanent essential arterial hypertension]. Levenson J; Simon A; Achimastos A; Temmar M; Safar M Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():167-70. PubMed ID: 6810821 [TBL] [Abstract][Full Text] [Related]
3. Endralazine, a new peripheral vasodilator--a randomized cross-over trial against dihydralazine. Kirch W; Axthelm T J Cardiovasc Pharmacol; 1982; 4(4):562-6. PubMed ID: 6181329 [TBL] [Abstract][Full Text] [Related]
4. Systemic and regional hemodynamic actions of calcium entry blockers in conscious spontaneously hypertensive rats. Nievelstein HM; Van Essen H; Tijssen CM; Smits JF; Struyker Boudier HA Eur J Pharmacol; 1985 Jul; 113(2):187-98. PubMed ID: 4043211 [TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and vascular activity of LY127210, a new vasodilator, in anesthetized spontaneously hypertensive rats: comparison with hydralazine. Steinberg MI; Keller CE; Bemis KG Clin Exp Hypertens A; 1985; 7(10):1481-97. PubMed ID: 3841035 [TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro genotoxicity of three antihypertensive hydrazine derivatives (hydralazine, dihydralazine, and endralazine). de Flora S; Zanacchi P; Bennicelli C; Camoirano A; Cavanna M; SciabĂ L; Cajelli E; Faggin P; Brambilla G Environ Mutagen; 1982; 4(5):605-19. PubMed ID: 7140679 [TBL] [Abstract][Full Text] [Related]
7. Acute hemodynamic effects of endralazine: a new vasodilator for chronic refractory congestive heart failure. Quyyumi AA; Wagstaff D; Evans TR Am J Cardiol; 1983 May; 51(8):1353-7. PubMed ID: 6846162 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic characterization of pinacidil in rats. Comparison with hydralazine. Thoolen MJ; Van Meel JC; Wilffert B; Timmermans PB; van Zwieten PA Pharmacology; 1983; 27(5):245-54. PubMed ID: 6318232 [TBL] [Abstract][Full Text] [Related]
9. Hemodynamic profile of N-(2,5-dimethyl-1H-pyrrol-1-yl)6-(4-morpholinyl)-3-pyridazinamine hydrochloride in conscious dogs. Di Francesco GF; Baldoli E; Marchetti G; Glässer A Arzneimittelforschung; 1986; 36(1):84-8. PubMed ID: 3954821 [TBL] [Abstract][Full Text] [Related]
10. Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure. Franciosa JA; Cohn JN Am J Med; 1978 Jul; 65(1):126-33. PubMed ID: 685986 [TBL] [Abstract][Full Text] [Related]
11. Effects of the vasodilator endralazine given with the antihypertensive agent guanfacine on heart rate and blood pressure of spontaneously hypertensive rats and normotensive dogs. Salzmann R; Gerber W; Pally C; Scholtysik G J Pharm Pharmacol; 1983 May; 35(5):293-8. PubMed ID: 6134797 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator. Baldoli E; Bianchi G; Corsico N; Di Francesco GF Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874 [TBL] [Abstract][Full Text] [Related]
14. Comparative hemodynamic studies of isradipine and dihydralazine in atherosclerotic and normal rabbits. Hof RP; Hof A; Takiguchi Y J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S13-22. PubMed ID: 1695297 [TBL] [Abstract][Full Text] [Related]
15. Lack of vasodilatory response in skeletal muscle blood vessels of aged spontaneously hypertensive rats. Horiuchi K; He H; Tomohiro A; Aki Y; Kimura S; Tamaki T; Abe Y Heart Vessels; 1996; 11(1):1-9. PubMed ID: 9119799 [TBL] [Abstract][Full Text] [Related]
16. Effects of the renal vasodilator prodrug CGP 22 979A and its parent compound CGP 18 137A on renal and central hemodynamics in conscious spontaneously hypertensive rats. Nievelstein HM; van Essen H; Hornsveld R; Struyker-Boudier HA; Smits JF J Pharmacol Exp Ther; 1985 Dec; 235(3):778-82. PubMed ID: 4078731 [TBL] [Abstract][Full Text] [Related]
17. Chronic arterial vasodilation, central hemodynamics, and cardiac hypertrophy in spontaneously hypertensive rats. Yuan B; Leenen FH J Cardiovasc Pharmacol; 1992 Jun; 19(6):922-8. PubMed ID: 1376814 [TBL] [Abstract][Full Text] [Related]
18. Role of baroreflex activation in the regional hemodynamic effects of the beta-blockers tertatolol and propranolol in conscious spontaneously hypertensive rats. Struyker-Boudier HA; van Essen H; Nievelstein HM; Smits JF Am J Nephrol; 1986; 6 Suppl 2():25-9. PubMed ID: 2879469 [TBL] [Abstract][Full Text] [Related]
19. Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats. Mitchell GF; Pfeffer MA; Finn PV; Pfeffer JM Circulation; 1996 Dec; 94(11):2923-9. PubMed ID: 8941122 [TBL] [Abstract][Full Text] [Related]
20. Studies in the rat on endralazine, a new antihypertensive drug structurally related to hydralazine. Oates HF; Stoker LM Clin Exp Pharmacol Physiol; 1981; 8(2):133-9. PubMed ID: 7018762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]